Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $20.04 USD
Change Today +0.17 / 0.86%
Volume 219.6K
SGNT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey M. Yordon

AgeTotal Calculated CompensationThis person is connected to 7 board members in 2 different organizations across 4 different industries.

See Board Relationships
66--
As of Fiscal Year 2014

Background*

Mr. Jeffrey M. Yordon Founded Sagent Pharmaceuticals, Inc. in 2006 and served as its Chairman and Chief Executive Officer since April 2006 until March 2015. Mr. Yordon served as the President of Sagent Pharmaceuticals from April 2006 to March 25, 2013. He has more than 35 years of injectables experience. He served as the Chairman, President and Chief Strategic Officer of Fresenius Kabi Pharmaceuticals Holding, Inc. He served as a Co-Chief Operating Officer of Fresenius ...

Read Full Background

Corporate Headquarters*

1901 North Roselle Road
Schaumburg, Illinois 60195

United States

Phone: 847-908-1600
Fax: 847-908-1601

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BSBA
Northern Illinois University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGNT:US $20.04 USD +0.17

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAGENT PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.